Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status
Luigi Formisano(University of Naples Federico II), Roberto Bianco(University of Naples Federico II)
Cited by 42
Related Papers
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
|Journal of Clinical Medicine|2020|105
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers
|British Journal of Cancer|2017|99
The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models
|British Journal of Cancer|2014|86
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells
|British Journal of Cancer|2014|58
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors
|Journal of Experimental & Clinical Cancer Research|2025|0